COMMUNIQUÉS West-GlobeNewswire
-
XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis
09/06/2017 - 21:10 -
Medable Launches Synapse, a Fully Integrated Clinical Care App Platform Using CareKit
09/06/2017 - 19:10 -
Medable lance Synapse, une plateforme d'application de soins cliniques intégralement intégrée utilisant CareKit
09/06/2017 - 19:10 -
Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
09/06/2017 - 17:45 -
Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017
09/06/2017 - 17:38 -
Targovax ASA: Notice of Extraordinary General Meeting
09/06/2017 - 15:41 -
Sixth Annual HOOPP LEAP Awards Honours Property Managers and Tenants for Outstanding Performance, Collaboration and Innovation
09/06/2017 - 14:00 -
La sixième cérémonie annuelle de remise des prix HOOPP LEAP honore les gestionnaires immobiliers et les locataires pour un rendement, une collaboration et une innovation exceptionnels
09/06/2017 - 14:00 -
Targovax ASA - Information on the subsequent offering - Key date information
09/06/2017 - 07:52 -
Mithra Pharmaceuticals: MITHRA RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY
09/06/2017 - 07:30 -
KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
09/06/2017 - 06:58 -
NICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE
09/06/2017 - 01:05 -
Communiqué rectificatif: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597.897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approb...
09/06/2017 - 00:05 -
TARGOVAX ASA - SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
08/06/2017 - 22:30 -
Novartis presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting
08/06/2017 - 22:30 -
Nicox: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597 897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approbation du ZERVIATE
08/06/2017 - 20:00 -
Nicox: Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to existing Aciex shareholders following the US FDA's approval of ZERVIATE
08/06/2017 - 20:00 -
Solon Eiendom ASA - Primary insider notification
08/06/2017 - 18:08 -
CROSSJECT : point d'activité
08/06/2017 - 18:00
Pages